SCHEMBL4434059

SCHEMBL4434059

O=C(O)NNC1CCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 7/20 0.46
SMN1; SMN2 Q16637 6/20 0.46
NPC1 O15118 5/20 0.46
RAB9A P51151 3/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.46
CYP3A4 P08684 1/20 0.46
EPHX2 P34913 1/20 0.46
HTT P42858 2/20 0.40
GAA P10253 1/20 0.40
MMP2 P08253 4/20 0.39
CA12 O43570 3/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA9 Q16790 3/20 0.39
MMP1 P03956 2/20 0.39
MMP8 P22894 1/20 0.38
MMP3 P08254 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15540703 0.97 EPHX1 (0.50) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL1512806 0.94
SCHEMBL27945455 0.80 EPHX1 (0.50) EPHX1SMN1; SMN2MAPTKDM4EEPHX2
SCHEMBL28138206 0.80 ALDH1A1 (0.33) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL22991205 0.79 EPHX1 (0.42) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL25978974 0.79 SMN1; SMN2 (0.42) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL27706683 0.79 SMN1; SMN2 (0.42) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL16611327 0.77 HDAC3 (0.35) ALDH1A1MAPTMAPK1
SCHEMBL24514487 0.77 EPHX1 (0.46) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL141382 0.77 EPHX1 (0.46) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118106-A1 PURINES AS CYSTEINE PROTEASE INHIBITORS Glaxo Group Limited (GB) 2009-11-18 EP claimed
WO-2008107368-A1 PURINES AS CYSTEINE PROTEASE INHIBITORS GLAXO GROUP LIMITED (GB) 2008-09-12 WO claimed
EP-2118106-A1 PURINES AS CYSTEINE PROTEASE INHIBITORS Glaxo Group Limited (GB) 2009-11-18 EP disclosed
WO-2008107368-A1 PURINES AS CYSTEINE PROTEASE INHIBITORS GLAXO GROUP LIMITED (GB) 2008-09-12 WO disclosed
CN-1777608-A fused pyrimidine derivatives KYOWA HAKKO KOGYO KK (JP) 2006-05-24 CN disclosed